Interim Results for six months to 31 December 2025

Rainbow Rare Earths Limited (AIM:RBW) recently announced its interim results for the six months ending December 31, 2025, highlighting notable progress at its Phalaborwa project in South Africa and the Uberaba project in Brazil. The announcement claims that the Phalaborwa project is now a proven producer of rare earth elements (REE) from phosphogypsum, with ongoing evaluations of solvent extraction processes aimed at refining its mixed rare earth product into higher-value outputs. While the headline suggests a positive trajectory for the company, a deeper examination reveals a mixed picture, particularly when compared to prior disclosures and the broader market context.

In its previous updates, Rainbow Rare Earths had set ambitious targets for its projects. The company had previously disclosed an Interim Economic Study in December 2024, which estimated a post-tax NPV of US$611 million for the Phalaborwa project, with an internal rate of return (IRR) of 38% and an average EBITDA of US$180 million per annum over a 16-year project life. The latest announcement indicates that the Definitive Feasibility Study (DFS) is expected to be published later in 2026, which will update these economic metrics. However, the lack of concrete figures in the interim results raises questions about the progress made since the last report. The announcement also notes that the DFS will address inflationary impacts, suggesting that previous estimates may be under pressure, which could be a concern for investors.

Financially, Rainbow Rare Earths reported a successful equity subscription that raised approximately US$14.6 million at £0.20 per share, completed on March 31, 2026. This capital is earmarked for completing the Phalaborwa DFS and advancing the Uberaba project. However, the reliance on equity financing raises potential dilution concerns for existing shareholders. The company's current market capitalisation stands at GBP 139.3 million, and with the new funds, it is essential to assess whether this capital will be sufficient to meet the ambitious timelines and project requirements outlined in the announcement. The company has indicated that the funds will support operations beyond the end of Q2 2027, which provides some assurance regarding its runway but also highlights the need for ongoing capital to sustain its growth trajectory.

In terms of valuation, Rainbow Rare Earths' current market cap of GBP 139.3 million positions it within a competitive landscape of rare earth element producers. The company's Uberaba project has been highlighted with a post-tax NPV of US$916 million and an IRR of 45%, which could suggest strong potential if realized. However, without direct peer comparisons, it is challenging to ascertain whether this valuation is attractive. For instance, companies such as Pensana Plc (AIM:PRE) and Lynas Rare Earths Limited (ASX:LYC) are also active in the REE sector, with Lynas boasting a market cap significantly higher than Rainbow's while delivering established production metrics. This disparity raises questions about whether Rainbow's projects can deliver comparable returns and whether the market is pricing in the risks associated with its development stage.

The execution track record of Rainbow Rare Earths has shown some promise, particularly with the successful establishment of the Phalaborwa project as a producer of REE. However, the company has faced challenges in meeting prior guidance, as evidenced by the need for further studies and the ongoing evaluations of extraction processes. The announcement's reference to the pilot plant in Johannesburg producing a high-grade mixed rare earth product is a positive development, yet it must be viewed in the context of the overall project timeline and the company's historical performance. The upcoming DFS is a critical milestone that will provide clarity on the project's economic viability, but any delays or revisions could further erode investor confidence.

One notable red flag in this announcement is the potential for dilution stemming from the recent equity raise. While the funding is necessary for project advancement, the terms of the equity subscription at a price of £0.20 per share may not reflect the intrinsic value of the company, especially if the market perceives the need for ongoing capital raises as a sign of financial instability. Furthermore, the announcement's optimistic tone regarding REE pricing, which has seen significant increases, must be tempered by the understanding that market dynamics can shift rapidly, particularly in a sector influenced by geopolitical factors such as export controls from China.

Looking ahead, the next expected catalyst for Rainbow Rare Earths is the publication of the Definitive Feasibility Study for the Phalaborwa project, anticipated later in 2026. This study will be pivotal in determining the project's economic outlook and could significantly impact the company's valuation and investor sentiment. However, without a specific timeline for this release, uncertainty remains regarding the company's ability to execute its strategic vision.

In conclusion, while the interim results announcement from Rainbow Rare Earths presents several positive developments, including progress at both the Phalaborwa and Uberaba projects, the overall context suggests a more cautious interpretation. The reliance on equity financing raises dilution concerns, and the need for further studies indicates that the company may not be as far along in its development as previously suggested. The upcoming DFS will be a critical test of the company's claims, and until then, the announcement can be classified as moderate in significance, with the headline sentiment being somewhat optimistic given the underlying challenges. Investors should remain vigilant as the company navigates these complexities in the rare earths market.

Key insights

• ●Phalaborwa's DFS is expected later in 2026, raising questions on timelines.
• ●Recent equity raise at £0.20 per share introduces dilution risk for current shareholders.
• ●Uberaba's NPV of US$916 million suggests strong potential, but execution remains critical.

Disagree with this article?